WorldPingWhy a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody treatment for atopic dermatitis.
Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.
The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.
Read the full report at STAT
WorldPing"I would burn my equity to the ground in a heartbeat for a 1% higher chance we make it out of this situation alive,” wrote one researcher.
Brief by WorldPing · Original reporting by Fortune
WorldPing